10-Q/A XBRL

TPIV 10QA

Company: Marker Therapeutics, Inc.
Filed: September 12, 2012
Period of Report: June 30, 2012
Accession Number: 0001424884-12-000052

View Document ↗ View on SEC.gov ↗